Contribution: Industrial Research Assistance Program – Contributions to Firms
Spartan Bioscience Inc.
$687,928.00
COVID-19 Test Development
FY 2019-20 · 2020-03-23
Summary
Spartan Bioscience (Spartan) proposes development of a SARS-CoV-2 assay to operate on its Cube sample-to-result real-time PCR testing platform. The proposed assay will have a simple workflow requiring no sample preparation after sample collection. The portable size of the Cube, along with the simplicity of the proposed workflow allows the solution to be deployed and implemented into airports, border crossings, and critical national infrastructure with ease.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Ottawa|Ottawa, Ontario, Canada
Recipient Type
For-profit organization
Business Number
855952438
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-03-23 | 2019-20 | $273,928.00 |
| 1 | 2020-03-23 | 2019-20 | $687,928.00 |
| 2 | 2020-03-23 | 2019-20 | $687,928.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 92 jours.
Agreement End Date
2020-12-31
Agreement Number
947397
Agreement Start Date
2020-03-23
Agreement Title
COVID-19 Test Development
Agreement Title (French)
Mise au point du test de la COVID-19
Agreement Type
Contribution
Agreement Value
$687,928.00
Amendment Date
2020-11-27
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Spartan Bioscience (Spartan) proposes development of a SARS-CoV-2 assay to operate on its Cube sample-to-result real-time PCR testing platform. The proposed assay will have a simple workflow requiring no sample preparation after sample collection. The portable size of the Cube, along with the simplicity of the proposed workflow allows the solution to be deployed and implemented into airports, border crossings, and critical national infrastructure with ease.
Description (French)
Spartan Bioscience (Spartan) propose de mettre au point un test SRAS-CoV-2 qui fonctionnera sur sa plate-forme de test ACP en temps réel de l'échantillon au résultat. Le test proposé aura un processus simple ne nécessitant aucune préparation de l'échantillon après le prélèvement. La taille portable du Cube et la simplicité du processus proposé permettent de déployer et de mettre en œuvre facilement la solution dans les aéroports, les postes frontières et les infrastructures nationales essentielles.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Ottawa West--Nepean
Federal Riding (French)
Ottawa-Ouest--Nepean
Federal Riding Number
35079
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
855952438
Recipient City
Ottawa|Ottawa
Recipient Country
CA
Recipient Legal Name
Spartan Bioscience Inc.
Recipient Postal Code
K2H 1B2
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2019-2020-Q4-947397
